Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B +/- Flucytosine then Fluconazole vs Itraconazole for Cryptococcal Meningitis
NCT00000639Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of flucytosine, itraconazole and fluconazole in cryptococcal meningitis (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Cerebrospinal Fluid Sterilization at 2 weeks. Status: completed.
02
Drugs
flucytosineitraconazolefluconazole
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT00000639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000639.